Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date.

Although improvements in motor scores were reported in the group of patients treated with pridopidine 90 mg/d, the differences compared with placebo did not reach statistical significance.

also in 111,027 other papers

The results of this study showed a strong trend toward improvement – close to statistical significance for the primary endpoint.

also in 5,725 other papers